Arvaya Healthcare Limited has closed its trading window for Designated Persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of its unaudited financial results for the first quarter ended June 30, 2026. The measure is implemented to comply with the SEBI (Prohibition of Insider Trading) Regulations, 2015, ensuring that no insider trading occurs during the period leading up to the financial announcement.

The Board Meeting date for the declaration of the unaudited financial results for Q1FY26 will be intimated separately. The company has emphasized that the closure applies to Designated Persons, along with their immediate relatives and persons with whom they share a material financial relationship.

To further strengthen compliance, the company has adopted a framework laid down by SEBI via a circular dated July 19, 2023. This framework involves freezing the Permanent Account Number (PAN) of all Designated Persons and their relatives at the security level during the Trading Window closure period. The restriction is designed to rationalize compliance requirements and prevent inadvertent non-compliance under the PIT Regulations.

The intimation was submitted to BSE Limited on June 22, 2026, by Kaushal Uttam Shah, Managing Director of Arvaya Healthcare Limited. The company, formerly known as Bijoy Hans Limited, requested the exchange to disseminate the information on its website.

Arvaya Healthcare Limited has corrected an inadvertent error in the Earnings Per Share (EPS) figures reported in its Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The company submitted a corrigendum to the Bombay Stock Exchange on June 03, 2026, to rectify the discrepancy in the EPS (Basic and Diluted) for continuing operations.

The revised financial data confirms that the consolidated net profit for Q4FY26 stood at ₹146.76 lakh, a turnaround from the loss of ₹20.52 lakh in the corresponding period of the previous year. Total revenue from operations for the quarter was ₹911.33 lakh. For the full financial year FY26, the company reported a consolidated net profit of ₹90.38 lakh on revenue of ₹911.33 lakh. The standalone entity continued to report a net loss of ₹63.35 lakh for the quarter and ₹119.73 lakh for the year, with zero revenue from operations.

Financial Performance

The consolidated results incorporate the performance of three wholly-owned subsidiaries acquired on March 4, 2026: Health Secure Hospitals Private Limited, Arvaya Health and Wellness Private Limited, and Tec-Pool Solutions Private Limited. The company recognised provisional goodwill of ₹20,32,26,741 on these acquisitions. Consequently, the results for the current period are not directly comparable with the previous year.

Acquisitions and Governance

The total purchase consideration for the acquisitions amounted to ₹60,65,22,950. The Board approved an increase in authorised share capital from ₹60 crore to ₹200 crore in March 2026, later approved by shareholders in April 2026. The company changed its name from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" effective May 11, 2026.

The statutory auditors, M/s. Khire Khandekar & Kirloskar, issued an unmodified opinion on the financial statements. The corrigendum was signed by Kaushal Uttam Shah, Managing Director.